Yu-Ling Lai Selected Research

Yu-Ling Lai Research Topics

5	Type 2 Diabetes Mellitus (MODY) 07/2010 - 09/2009
3	Hypercholesterolemia 07/2010 - 11/2006
2	Prediabetic State (Prediabetes) 07/2010 - 09/2009
1	Hypotension (Low Blood Pressure) 12/2023
1	Pain (Aches) 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 12/2023
1	Glioblastoma (Glioblastoma Multiforme) 05/2021
1	Abnormal Karyotype 03/2013
1	Insulin Resistance 04/2010
1	Hyperglycemia 09/2009
1	Glucose Intolerance 09/2009
1	Coronary Disease (Coronary Heart Disease) 11/2006

6	Colesevelam Hydrochloride (Welchol)FDA Link 07/2010 - 11/2006
4	LDL CholesterolIBA 07/2010 - 11/2006
4	LipidsIBA 07/2010 - 09/2009
3	Glucose (Dextrose)FDA LinkGeneric 07/2010 - 09/2009
3	oxidized low density lipoproteinIBA 07/2010 - 11/2006
3	Metformin (Glucophage)FDA LinkGeneric 07/2010 - 09/2009
2	Lipoproteins (Lipoprotein)IBA 01/2010 - 09/2009
1	Anesthetics (Anesthetic Agents)IBA 12/2023
1	Propofol (Diprivan)FDA LinkGeneric 12/2023
1	Intravenous AnestheticsIBA 12/2023
1	Temozolomide (Temodar)FDA LinkGeneric 05/2021
1	CateninsIBA 05/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2021
1	Biomarkers (Surrogate Marker)IBA 03/2013
1	Bile Acids and Salts (Bile Acids)IBA 07/2010
1	Triglycerides (Triacylglycerol)IBA 07/2010
1	Hemoglobins (Hemoglobin)IBA 07/2010
1	Insulin (Novolin)FDA Link 04/2010
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2010
1	Rosiglitazone (Avandia)FDA Link 01/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2009
1	Ezetimibe (Zetia)FDA Link 11/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2006